A clinical trial of avapritinib versus regorafenib (Stivarga®) for people with advanced GIST that has progressed following first-line treatment with imatinib (Gleevec®) and one or two additional treatment regimens (third-line or fourth-line GIST).
Mayo Clinic’s Arizona campus is ranked the #1 hospital in Arizona according to U.S. News & World Report. Mayo Clinic treats more than 120,000 people with cancer each year. U.S. News & World Report consistently ranks Mayo Clinic among the top hospitals for cancer in the nation. Mayo Clinic cancer experts are trained and experienced in the latest, most effective cancer treatment techniques.
Phoenix Arizona Clinical Trial Location
Mayo Clinic Cancer Center
5881 E Mayo Blvd
Phoenix, AZ 85054